Organisation paid for research Program year 2025 Source: CMS Open Payments

Aultman Hospital

Neither a doctor nor a teaching hospital

Research payments

$571,858

13 payments

Through program year 2025, Aultman Hospital is reported as receiving $571,858 in research payments, across 13 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$206,516	4
2024	Research	$222,603	1
2023	Research	$141,777	5
2022	Research	$772	2
2021	Research	$189	1

Breakdown

Who paid Research payments · program years 2021–2025

Novartis Pharmaceuticals Corporation $535,466 6 payments
GlaxoSmithKline, LLC. $31,431 2 payments
Boston Scientific Corporation $4,188 3 payments
E.R. Squibb & Sons, L.L.C. $772 2 payments

Studies the money was for Research payments · program years 2021–2025

Hps-4/Timi 65/Orion-4: A Double-Blind Randomized Placebo-Controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease $535,466 6 payments
A Randomized, Double-Blind, Phase 3 Comparison of Platinum-Based Thera $31,431 2 payments
Lux DX Perform $4,188 3 payments
Ph II MORAb-202 in 2L Platinum Resistant Ovarian Cancer $756 1 payment
Phase III Study - Breast Cancer HR Pos / HER2 Neg Neo adjuvant $17 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.